Page last updated: 2024-11-07

metaraminol and Endotoxemia

metaraminol has been researched along with Endotoxemia in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.

Research Excerpts

ExcerptRelevanceReference
"We hypothesised that in septic shock there is an impaired autoregulation of microcirculation, and blood flow is totally dependent on CDP."1.42Endotoxaemic myocardial dysfunction: the role of coronary driving pressure in subendocardial perfusion. ( Ariga, SK; Batista, TR; Lorigados, CB; Soriano, FG; Velasco, IT, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lorigados, CB1
Ariga, SK1
Batista, TR1
Velasco, IT1
Soriano, FG1

Other Studies

1 other study available for metaraminol and Endotoxemia

ArticleYear
Endotoxaemic myocardial dysfunction: the role of coronary driving pressure in subendocardial perfusion.
    Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2015, Volume: 17, Issue:1

    Topics: Animals; Coronary Circulation; Coronary Vessels; Endotoxemia; Heart; Hemodynamics; Male; Metaraminol

2015